Ultragenyx Pharmaceutical Inc (RARE) Gross Profit Margin starting from the second quarter 2026 to second quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Ultragenyx Pharmaceutical Inc   (NASDAQ: RARE)


Ultragenyx Pharmaceutical Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RARE Gross Profit Margin (Jun 30 2026)
Q2 		(Mar 31 2026)
Q1 		(Dec 31 2025)
Q4 		(Sep 30 2025)
Q3 		(Jun 30 2025)
Q2
Y / Y Revenue Change 28.53 %
Seq. Revenue Change 57.35 %
Revenue In Millions $214.00
Gross Profit Margin 0 %
Gross Profit Margin Total Ranking # 1313
Gross Profit In Millions $0.00
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting Second Quarter 2026 Gross Profit Margin
Ultragenyx Pharmaceutical Inc recorded Gross Loss compared to Gross Profit achieved in the preceding quarter.


Observing second quarter 2026 results within Major Pharmaceutical Preparations industry 158 other companies have achieved higher Gross Profit Margin. While overall Gross Profit Margin ranking remained unchanged compared to the previous quarter at no. .
Learn about Gross Margin
RARE's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 159
Healthcare Sector # 283
Overall # 1313

Gross Profit Margin Statistics
High Average Low
101.67 % 92.41 % 77.94 %
(Dec 31 2020)   (Mar 31 2026)


RARE Gross Income Trends • More of RARE's Profitabilty Ratios • RARE Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
RARE's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
RARE's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for RARE's Competitors
Gross Profit Margin Profit Margin for Ultragenyx Pharmaceutical Inc 's Suppliers
Gross Profit Margin Profit Margin for RARE's Customers

You may also want to know
RARE's Annual Growth Rates RARE's Profitability Ratios RARE's Asset Turnover Ratio RARE's Dividend Growth
RARE's Roe RARE's Valuation Ratios RARE's Financial Strength Ratios RARE's Gross Profit Growth
RARE's Roa RARE's Inventory Turnover Ratio RARE's Growth Rates RARE's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2026, within Major Pharmaceutical Preparations Industry Gross Profit MarginJun 30 2026 MRQ Gross ProfitJun 30 2026 MRQ Revenue




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.